A detailed history of Atwater Malick LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atwater Malick LLC holds 892 shares of LLY stock, worth $713,510. This represents 0.26% of its overall portfolio holdings.

Number of Shares
892
Previous 892 -0.0%
Holding current value
$713,510
Previous $807,000 2.11%
% of portfolio
0.26%
Previous 0.28%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

BUY
$350.74 - $468.98 $312,860 - $418,330
892 New
892 $418,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Atwater Malick LLC Portfolio

Follow Atwater Malick LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.